BES2021 Belgian Endocrine Society 2021 Abstracts (26 abstracts)
Characteristics, pregnancy outcomes and tolerance of screening tests according to the preference of women for the method of GDM screening
Raets Lore 1 , Vandewinkel Marie 2 , Van Crombrugge Paul 3 , Moyson Carolien 1 , Verhaeghe Johan 4 , Vandeginste Sofie 5 , Verlaenen Hilde 5 , Vercammen Chris 6 , Maes Toon 6 , Dufraimont Els 7 , De Block Christophe 8 , Jacquemyn Yves 9 , Mekahli Farah 10 , De Clippel Katrien 11 , Van Den Bruel Annick 12 , Loccufier Anne 13 , Laenen Annouschka 14 , Devlieger Roland 4 , Mathieu Chantal 1 & Benhalima Katrien 1
1Department of Endocrinology, UZ Gasthuisberg, KU Leuven, Belgium; 2Medicine, KU Leuven, Belgium; 3Department of Endocrinology, OLV ziekenhuis Aalst-Asse-Ninove, Belgium; 4Department of Obstetrics & Gynecology, UZ Gasthuisberg, KU Leuven, Belgium; 5Department of Obstetrics & Gynecology, OLV ziekenhuis Aalst-Asse-Ninove, Belgium; 6Department of Endocrinology, Imelda ziekenhuis, Belgium; 7Department of Obstetrics & Gynecology, Imelda ziekenhuis, Belgium; 8Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Belgium; 9Department of Obstetrics & Gynecology, Antwerp University Hospital, Belgium; 10Department of Endocrinology, Kliniek St-Jan Brussel, Belgium; 11Department of Obstetrics & Gynecology, Kliniek St-Jan Brussel, Belgium; 12Department of Endocrinology, AZ St Jan Brugge, Belgium; 13Department of Obstetrics & Gynecology, AZ St Jan Brugge, Belgium; 14Center of Biostatics and Statistical bioinformatics, Leuven, Belgium
Aims: To compare the characteristics, pregnancy outcomes and tolerance of screening tests between women who prefer a two-step screening strategy with a glucose challenge test (GCT), women who prefer an one-step screening strategy with an oral glucose tolerance test (OGTT) and women without clear preference for screening method for gestational diabetes mellitus (GDM).
Methods: 1803 women from a Belgian multi-centric prospective cohort study (BEDIP-N study) received both a GCT and a 75g oral OGTT using the IADPSG criteria. Tolerance of screening tests and preference for screening strategy were evaluated by a self-designed questionnaire at the time of the GCT and OGTT.
Results: Of all women, 46.3% (834) preferred two-step screening, 26.2% (472) preferred an one-step screening strategy and 27.6% (497) had no clear preference. Women who preferred one-step screening had more often complaints from the GCT compared to women who preferred two-step screening [25.0% (114) vs. 18.0% (146), P = 0.003], while women who preferred two-step screening had more complaints from the OGTT compared to women who preferred the one-step strategy [50.4% (420) vs. 40.3% (190), P < 0.001] or women without preference [50.4% (420) vs. 34.9% (173), P < 0.001]. There was no difference in rate of parity between groups. Compared to women who preferred one-step screening, women who preferred two-step screening had less often an ethnic minority background [6.0% (50) vs. 10.7% (50), P = 0.003], had less often a low income [1.8% (15) vs. 5.0% (23), P = 0.003], had less often a first degree family history of GDM [3.8% (29) vs. 6.4% (28), P = 0.039] or a previous history of GDM [7.3% (29) vs. 13.8% (32), P = 0.008], had a lower BMI [23.9 ± 4.0 vs. 25.4 ± 5.3, P < 0.001), were less overweight or obese [respectively 23.1% (50) vs. 24.8% (116), P < 0.001 and 7.9% (66) vs. 18.2% (85), P < 0.001], and less insulin resistant in early pregnancy (HOMA-IR 8.9 (6.4-12.3) vs. 9.9 (7.2-14.2), P < 0.001]. Pregnancy outcomes were similar, except for a lower rate of labour inductions and emergency caesarean sections (CS) in the two-step screening group [respectively 26.6% (198) vs. 32.5% (137), P = 0.031 and 8.2% (68) vs. 13.0% (61), P = 0.005].
Conclusions: Women with a more adverse metabolic profile preferred one-step screening with OGTT while women who preferred two-step screening had a better metabolic profile, and more complaints of the OGTT.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more